Cantel Medical Corp

Cantel Medical Corp

Health CareHealth Care Equipment & Services
  • Price (USD)34.61
  • Today's Change-0.24 / -0.69%
  • Shares traded601.32k
  • 1 Year change-49.78%
  • Beta1.1693
Data delayed at least 15 minutes, as of May 22 2020 21:00 BST.
More ▼

Profile data is unavailable for this security.

About the company

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company's operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The Company's Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The Company's Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The Company offers a range of filters utilizing hollow fiber membrane technology.

  • Revenue in USD (TTM)1.01bn
  • Net income in USD21.22m
  • Incorporated1963
  • Employees2.78k
  • Location
    Cantel Medical Corp150 Clove RdLITTLE FALLS 07424-2138United StatesUSA
  • Phone+1 (973) 890-7220
  • Fax+1 (973) 890-7270
  • Websitehttp://www.cantelmedical.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CMD:NYQ since
Hu-Friedy Mfg Co LLCDeal completed30 Jul 201930 Jul 2019Deal completed-57.91%775.00m
Data delayed at least 15 minutes, as of May 22 2020 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Orthopediatrics Corp74.25m-14.61m833.01m94.00--5.67--11.22-0.9557-1.034.918.250.51890.50186.08789,914.90-10.21-13.18-11.17-14.8375.6673.66-19.68-19.705.14-2.800.132--26.0525.09-5.49--29.50--
Cryolife Inc275.15m-4.77m862.75m1.20k--3.1261.363.14-0.1286-0.12447.357.330.45561.875.34229,288.30-0.79520.816-0.85170.885166.4865.80-1.751.583.661.140.475820.815.0913.81150.90-26.348.70--
Inmode Ltd156.36m61.15m932.98m209.0015.56--15.185.971.681.684.33------------------87.06--39.11----------56.11--173.32------
Tactile Systems Technology Inc195.55m8.19m944.92m629.00117.608.3682.424.830.41780.417810.025.881.455.527.46310,890.306.
Atrion Corporation157.05m36.21m1.20bn616.0033.485.1025.307.6119.4419.4584.34127.720.62642.307.13254,944.8014.4416.1015.1716.9345.7547.3323.0521.616.70--0.0026.061.721.957.275.7310.0415.84
Adapthealth Corp601.59m-9.35m1.23bn3.06k----72.492.05-0.2502-0.250221.01-0.14421.31----196,596.40-1.56---1.93--14.84---1.19--0.92370.82131.06-------818.85------
Cardiovascular Systems Inc262.23m-10.60m1.31bn731.00--9.12--4.98-0.3114-0.31147.734.061.222.407.97358,731.90-4.92-9.79-6.22-12.1980.1480.43-4.04-8.662.80--0.1272--14.2712.67-114.89---23.33--
Avanos Medical Inc713.80m-21.90m1.35bn4.70k--1.0778.221.88-0.4602-0.460214.9626.310.39682.184.85151,872.30-1.22-2.78-1.38-3.2856.8855.49-3.07-9.381.963.150.165--6.94-16.04-270.16---8.41--
Shockwave Medical Inc50.85m-57.09m1.42bn284.00--7.97--27.85-1.93-1.931.735.580.26891.728.66179,063.40-30.18---33.10--61.19---112.25--9.68-60.100.0832--250.05---24.35------
Luminex Corporation342.65m-12.66m1.44bn1.25k--3.0488.304.21-0.2868-0.13777.7110.370.63722.185.42274,782.70-2.374.05-2.614.4554.6663.17-3.726.422.40-6.030.0037.365.968.07-190.44---1.02--
Cantel Medical Corp.1.01bn21.22m1.46bn2.78k68.212.0419.991.440.50740.4924.0916.990.6963.576.85365,323.301.468.311.649.6047.1446.962.098.401.246.310.55979.615.3013.44-31.015.8147.7817.67
Axonics Modulation Technologies Inc39.04m-81.43m1.52bn302.00--7.77--38.91-2.76-2.761.305.000.20721.303.62129,268.20-43.22---46.50--59.43---208.60--9.31--0.1066--1,854.74---146.08------
Glaukos Corp238.29m-37.29m1.66bn600.00--2.58--6.96-1.11-1.115.5414.540.47293.119.63397,156.70-7.40-3.00-8.03-3.4273.1485.09-15.65-4.113.99-42.620.0847--30.7339.05219.10--40.33--
Patterson Companies, Inc.5.64bn48.13m1.67bn7.80k34.261.1312.890.29560.50790.507959.7415.341.655.1711.30723,109.801.384.512.015.9121.5623.430.83532.870.68786.350.316860.461.999.23-34.90-13.9312.288.87
STAAR Surgical Company152.79m12.55m1.74bn550.00143.9310.52109.9211.360.26740.26743.293.660.79582.375.00277,798.206.530.77597.701.0073.6572.258.210.73875.17--0.0120.0021.1614.90182.77--20.21--
Inari Medical Inc51.13m-1.19m1.96bn--------38.31-0.1242-0.12425.33------------------88.44---2.33----0.9639----648.73--88.26------
Data as of May 22 2020. Currency figures normalised to Cantel Medical Corp's reporting currency: US Dollar USD

Institutional shareholders

58.04%Per cent of shares held by top holders
HolderShares% Held
Brown Capital Management LLCas of 31 Mar 20203.92m9.30%
Champlain Investment Partners LLCas of 31 Mar 20203.67m8.71%
The Vanguard Group, Inc.as of 31 Mar 20203.38m8.01%
BlackRock Fund Advisorsas of 31 Mar 20203.22m7.65%
Fred Alger Management LLCas of 31 Mar 20202.35m5.57%
Wasatch Advisors, Inc.as of 31 Mar 20202.01m4.77%
Neuberger Berman Investment Advisers LLCas of 31 Mar 20201.81m4.29%
Janus Capital Management LLCas of 31 Mar 20201.55m3.68%
Mackenzie Financial Corp.as of 31 Mar 20201.39m3.31%
Diker Management LLCas of 31 Mar 20201.16m2.76%
More ▼
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.